Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Gilead Sciences to Acquire Ouro Medicines for $2.2 Billion, Ushering in New Era of T-Cell Engagers in Autoimmune Diseases
Gilead Sciences is poised to make a significant entry into the burgeoning field of T-cell engagers (TCEs) with its $2.2…
Read More
Ancient Genetic Fragments Reshape Cancer Genomes Years Before Diagnosis, Ushering in a New Era of Early Detection and Therapeutic Understanding
A groundbreaking study published in the prestigious journal Science has fundamentally reshaped our understanding of cancer evolution, revealing that ancient…
Read More
